Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Di Molfetta

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Expert Review of Medical Devices|April 4, 2025
An overview of the FreeStyle Libre monitoring system for individuals with type 1 and type 2 diabetesSergio Di Molfetta, Antonio Cutruzzolà, Agostino Gnasso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2024
Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert OpinionSergio Di Molfetta, Antonio Rossi, Federico Boscari, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 8, 2024
Publisher Correction to: Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert OpinionSergio Di Molfetta, Antonio Rossi, Federico Boscari, et al.
Endocrine-Related Cancer|April 13, 2018
Pasireotide in the treatment of neuroendocrine tumors: a review of the literatureGiovanni Vitale, Alessandra Dicitore, Concetta Sciammarella, et al.
Frontiers in Endocrinology|July 5, 2021
Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical ManagementGiuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, et al.
Journal of Clinical Medicine|February 25, 2022
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?Sergio Di Molfetta, Tiziana Feola, Giuseppe Fanciulli, et al.
Diabetes, Obesity & Metabolism|January 20, 2023
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysisSergio Di Molfetta, Irene Caruso, Angelo Cignarelli, et al.
Frontiers in Endocrinology|May 3, 2021
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?Sergio Di Molfetta, Andrea Dotto, Giuseppe Fanciulli, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory StudyMartina Parise, Sergio Di Molfetta, Roberta Teresa Graziano, et al.
Nutrients|August 26, 2022
The Effect of Two Different Insulin Formulations on Postprandial Hyperglycemia after High and Low Glycemic-Index Meal in Type 1 DiabetesAntonio Cutruzzolà, Martina Parise, Raffaella Fiorentino, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Review of Medical Devices|April 4, 2025
An overview of the FreeStyle Libre monitoring system for individuals with type 1 and type 2 diabetesSergio Di Molfetta, Antonio Cutruzzolà, Agostino Gnasso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2024
Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert OpinionSergio Di Molfetta, Antonio Rossi, Federico Boscari, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 8, 2024
Publisher Correction to: Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert OpinionSergio Di Molfetta, Antonio Rossi, Federico Boscari, et al.
Endocrine-Related Cancer|April 13, 2018
Pasireotide in the treatment of neuroendocrine tumors: a review of the literatureGiovanni Vitale, Alessandra Dicitore, Concetta Sciammarella, et al.
Frontiers in Endocrinology|July 5, 2021
Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical ManagementGiuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, et al.
Journal of Clinical Medicine|February 25, 2022
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?Sergio Di Molfetta, Tiziana Feola, Giuseppe Fanciulli, et al.
Diabetes, Obesity & Metabolism|January 20, 2023
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysisSergio Di Molfetta, Irene Caruso, Angelo Cignarelli, et al.
Frontiers in Endocrinology|May 3, 2021
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?Sergio Di Molfetta, Andrea Dotto, Giuseppe Fanciulli, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory StudyMartina Parise, Sergio Di Molfetta, Roberta Teresa Graziano, et al.
Nutrients|August 26, 2022
The Effect of Two Different Insulin Formulations on Postprandial Hyperglycemia after High and Low Glycemic-Index Meal in Type 1 DiabetesAntonio Cutruzzolà, Martina Parise, Raffaella Fiorentino, et al.
Pageof 4